Profiel
Dr. Konstantinos Karatzas is a Chief Executive Officer & Director at Acesis Holdings Corp.
He is on the Board of Directors at Acesis Holdings Corp.
and Applied Biotech Intelligence.
Dr. Karatzas was previously employed as a Chief Executive Officer by Acesis, Inc. He received his undergraduate degree from National & Kapodistrian University of Athens, a graduate degree from McGill University and an MBA from McGill University.
Actieve functies van Konstantinos Karatzas
| Bedrijven | Functie | Begin |
|---|---|---|
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders | Oprichter | 03-10-2022 |
Applied Biotech Intelligence | Directeur/Bestuurslid | 01-01-2015 |
Eerdere bekende functies van Konstantinos Karatzas
| Bedrijven | Functie | Einde |
|---|---|---|
Acesis, Inc.
Acesis, Inc. Packaged SoftwareTechnology Services Develops software solutions that offers data capture forms for physicians | Algemeen Directeur | - |
Opleiding van Konstantinos Karatzas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Acesis, Inc.
Acesis, Inc. Packaged SoftwareTechnology Services Develops software solutions that offers data capture forms for physicians | Technology Services |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National & Kapodistrian University of Athens
National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders | Health Technology |
Applied Biotech Intelligence |
















